Rein Therapeutics Presents Two Posters at the American Thoracic Society 2025 International Conference

Provided By PR Newswire

Last update: May 19, 2025

Presentations further support the dual mechanism of LTI-03 and the development of Cav1-related peptides for the treatment of idiopathic pulmonary fibrosis (IPF)